Gerardo Garcia-Rivas

Dr. Gerardo Garcia-Rivas

orcid

Research Focus & Metrics

Academic Career Length

24Years (2003-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 December 2006 in British Journal of Pharmacology
Verified
Journal Article
Open access
PDF file
GGGerardo Garcia-Rivas
Gerardo Garcia-Rivas
KCK Carvajal
K Carvajal
FCFrancisco Correa
Francisco Correa
CZCecilia Zazueta
Cecilia Zazueta
Background and purpose: The mitochondrial permeability transition pore (mPTP), an energy‐dissipating channel activated by calcium, contributes to reperfusion damage by depolarizing the mitochondrial inner membrane potential. As mitochondrial Ca2+ overload is a main inductor of mPTP opening, we examined the effect of Ru360, a selective inhibitor of the mitochondrial calcium uptake system against myocardial damage induced by reperfusion in a rat model.Experimental approach: Myocardial reperfusion injury was induced by a 5‐min occlusion of the left anterior descending coronary artery, followed by a 5‐min reperfusion in anaesthetized open‐chest rats. We measured reperfusion‐induced arrhythmias and functions indicative of unimpaired mitochondrial integrity to evaluate the effect of Ru360 treatment.Key results: Reperfusion elicited a high incidence of arrhythmias, haemodynamic dysfunction and loss of mitochondrial integrity. A bolus intravenous injection of Ru360 (15‐50 nmol kg−1), given 30‐min before ischaemia, significantly improved the above mentioned variables in the ischaemic/reperfused myocardium. Calcium uptake in isolated mitochondria from Ru360‐treated ventricles was partially diminished, suggesting an interaction of this compound with the calcium uniporter.Conclusions and implications: We showed that Ru360 treatment abolishes the incidence of arrhythmias and haemodynamic dysfunction elicited by reperfusion in a whole rat model. Ru360 administration partially inhibits calcium uptake, preventing mitochondria from depolarization by the opening of the mPTP. We conclude that myocardial damage could be a consequence of failure of the mitochondrial network to maintain the membrane potential at reperfusion. Hence, it is plausible that Ru360 could be used in reperfusion therapy to prevent the occurrence of arrhythmia.British Journal of Pharmacology (2006) 149, 829–837. doi:10.1038/sj.bjp.0706932

1 July 2021 in European Journal of Heart Failure
Verified
Journal Article
Closed access
PDF file
NRNestor Rubio‐Infante
Nestor Rubio‐Infante
YRYoel Adbel Ramírez-Flores
Yoel Adbel Ramírez-Flores
ECElena Cristina Castillo
Elena Cristina Castillo
OLOmar Lozano
Omar Lozano
GGGerardo Garcia-Rivas
Gerardo Garcia-Rivas
GTGuillermo Torre‐Amione
Guillermo Torre‐Amione

Verified
Journal Article
Open access
PDF file
Daniel N. Roffe-VazquezDaniel N. Roffe-Vazquez
Daniel N. Roffe-Vazquez
Anna S. Huerta-DelgadoAnna S. Huerta-Delgado
Anna S. Huerta-Delgado
ECElena C. Castillo
Elena C. Castillo
JVJose R Villarreal-Calderón
Jose R Villarreal-Calderón
AGAdrian Gonzalez-Gil
Adrian Gonzalez-Gil
LELeticia Elizondo-Montemayor
Leticia Elizondo-Montemayor
Vitamin D deficiency is highly prevalent worldwide. It has been associated with heart failure (HF) given its immunoregulatory functions. In-vitro and animal models have shown protective roles through mechanisms involving procollagen-1, JNK2, calcineurin/NFAT, NF-κB, MAPK, Th1, Th2, Th17, cytokines, cholesterol-efflux, oxLDL, and GLUT4, among others. A 12-month follow-up in HF patients showed a high prevalence of vitamin D deficiency, with no seasonal variation (64.7–82.4%). A positive correlation between serum 25(OH)D concentration and dietary intake of vitamin D-rich foods was found. A significant inverse correlation with IL-1β (R = −0.78), TNF-α (R = −0.53), IL-6 (R = −0.42), IL-8 (R = −0.41), IL-17A (R = −0.31), LDL-cholesterol (R = −0.51), Apo-B (R = −0.57), total-cholesterol (R = –0.48), and triglycerides (R = −0.32) was shown. Cluster analysis demonstrated that patients from cluster three, with the lowest 25(OH)D levels, presented the lowermost vitamin D intake, IL-10 (1.0 ± 0.9 pg/mL), and IL-12p70 (0.5 ± 0.4 pg/mL), but the highest TNF-α (9.1 ± 3.5 pg/mL), IL-8 (55.6 ± 117.1 pg/mL), IL-17A (3.5 ± 2.0 pg/mL), total-cholesterol (193.9 ± 61.4 mg/dL), LDL-cholesterol (127.7 ± 58.2 mg/dL), and Apo-B (101.4 ± 33.4 mg/dL) levels, compared with patients from cluster one. Although the role of vitamin D in the pathogenesis of HF in humans is still uncertain, we applied the molecular mechanisms of in-vitro and animal models to explain our findings. Vitamin D deficiency might contribute to inflammation, remodeling, fibrosis, and atherosclerosis in patients with HF.

18 April 2017 in Scientific Reports
Verified
Journal Article
Open access
PDF file
JGJavier A. Garza-Cervantes
Javier A. Garza-Cervantes
ACArturo Chávez-Reyes
Arturo Chávez-Reyes
ECElena C. Castillo
Elena C. Castillo
GGGerardo Garcia-Rivas
Gerardo Garcia-Rivas
OOOscar Ortega-Rivera
Oscar Ortega-Rivera
JMJosé Ruben Morones-Ramírez
José Ruben Morones-Ramírez
Due to the emergence of multi-drug resistant strains, development of novel antibiotics has become a critical issue. One promising approach is the use of transition metals, since they exhibit rapid and significant toxicity, at low concentrations, in prokaryotic cells. Nevertheless, one main drawback of transition metals is their toxicity in eukaryotic cells. Here, we show that the barriers to use them as therapeutic agents could be mitigated by combining them with silver. We demonstrate that synergism of combinatorial treatments (Silver/transition metals, including Zn, Co, Cd, Ni, and Cu) increases up to 8-fold their antimicrobial effect, when compared to their individual effects, against E. coli and B. subtilis. We find that most combinatorial treatments exhibit synergistic antimicrobial effects at low/non-toxic concentrations to human keratinocyte cells, blast and melanoma rat cell lines. Moreover, we show that silver/(Cu, Ni, and Zn) increase prokaryotic cell permeability at sub-inhibitory concentrations, demonstrating this to be a possible mechanism of the synergistic behavior. Together, these results suggest that these combinatorial treatments will play an important role in the future development of antimicrobial agents and treatments against infections. In specific, the cytotoxicity experiments show that the combinations have great potential in the treatment of topical infections.

25 April 2008 in Circulation Research
Verified
Journal Article
Closed access
PDF file
SMScott M. MacDonnell
Scott M. MacDonnell
GGGerardo Garcia-Rivas
Gerardo Garcia-Rivas
JSJoseph A. Scherman
Joseph A. Scherman
HKHajime Kubo
Hajime Kubo
XCXiongwen Chen
Xiongwen Chen
SHSteven R. Houser
Steven R. Houser
The sympathetic nervous system is a critical regulator of cardiac function (heart rate and contractility) in health and disease. Sympathetic nervous system agonists bind to adrenergic receptors that are known to activate protein kinase A, which phosphorylates target proteins and enhances cardiac performance. Recently, it has been proposed that protein kinase A–mediated phosphorylation of the cardiac ryanodine receptor (the Ca 2+ release channel of the sarcoplasmic reticulum at a single residue, Ser2808) is a critical component of sympathetic nervous system regulation of cardiac function. This is a highly controversial hypothesis that has not been confirmed by several independent laboratories. The present study used a genetically modified mouse in which Ser2808 was replaced by alanine (S2808A) to prevent phosphorylation at this site. The effects of isoproterenol (a sympathetic agonist) on ventricular performance were compared in wild-type and S2808A hearts, both in vivo and in isolated hearts. Isoproterenol effects on L-type Ca 2+ current ( I CaL ), sarcoplasmic reticulum Ca 2+ release, and excitation–contraction coupling gain were also measured. Our results showed that isoproterenol caused significant increases in cardiac function, both in vivo and in isolated hearts, and there were no differences in these contractile effects in wild-type and S2808A hearts. Isoproterenol increased I CaL , the amplitude of the Ca 2+ transient and excitation–contraction coupling gain, but, again, there were no significant differences between wild-type and S2808A myocytes. These results show that protein kinase A phosphorylation of ryanodine receptor Ser2808 does not have a major role in sympathetic nervous system regulation of normal cardiac function.

1 November 2014 in Cell Calcium
Verified
Journal Article
Closed access
AZAngel Zarain-Herzberg
Angel Zarain-Herzberg
GGGerardo Garcia-Rivas
Gerardo Garcia-Rivas
RERafael Estrada-Avilés
Rafael Estrada-Avilés